The decision making process on new vaccines introduction in South Africa

Vaccine

Volumn 30, Issue SUPPL.3, 2012, Pages C9-

  Ngcobo, Ntombenhle Judith ^a   Cameron, Neil A ^b  

^a NATIONAL DEPARTMENT OF HEALTH   (South Africa)

^b UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Cost effectiveness; Decision making; Immunisation policy; Introduction; New vaccines

Indexed keywords

BCG VACCINE; DIPHTHERIA PERTUSSIS POLIOMYELITIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; MEASLES VACCINE; PNEUMOCOCCUS VACCINE; POLIOMYELITIS VACCINE; VACCINE;

COST EFFECTIVENESS ANALYSIS; DIPHTHERIA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; HAEMOPHILUS INFECTION; HEALTH CARE POLICY; HEALTH PROGRAM; HEPATITIS B; HUMAN; MEASLES; MEDICAL DECISION MAKING; PERTUSSIS; PNEUMOCOCCAL INFECTION; POLIOMYELITIS; POLITICS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SOUTH AFRICA; TETANUS; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

EID: 84865652577     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.04.027     Document Type: Review

References (15)

1. Eastern and Southern Africa EPI Managers Meeting, Harare, 21-24 March 2011.
2. Von Gottberg A., De Gouveia L., Madhi S., et al. Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bulletin of the World Health Organization 2006, 84(October (10)):811-818.
3. World Health Organization. Immunisation, Vaccines and Biologicals. Vaccine Introduction Guidelines. Adding a vaccine to a national immunisation programme: decision and implementation. Ordering Code; WHO/IVB/05.18.
4. Chaiyakunapruk N., Somkrua R., Henao A.M., et al. Cost effectiveness of pediatric pneumococcal conjugate vaccines: a comparative assessment of decision making tools. BioMed Central 2011, 9(May (1)):53. http://www.biomedcentral.com/1741-7015/9/53.
5. Bryson M., Duclos P., Jolly A., Cakmak N. A global look at national Immunization Technical Advisory Groups. Vaccine 2010, 28S:A13-A17.
6. Schoub B.D., Ngcobo N., Shabir M. The National Advisory Group on Immunization (NAGI) of the Republic of South Africa. Vaccine 2010, 28S:A31-A34.
7. Klugman K.P., Madhi S.A., Huebner R.E., et al. A trial of 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection. The New England Journal of Medicine 2003, 349(October (14)):1341-1348.
8. Medicines and Related Substances Control Act, 1965. Act 101 of 1965 as Amended. Pretoria: Government Printers.
9. World Health Organization, UNICEF, World Bank State of the World Vaccines and Immunization 2009, World Health Organization, Geneva, p. 79. 3rd ed.
10. Ngcobo N., Cameron N. Introducing new vaccines into the childhood immunisation programme in South Africa. South African Journal of Epidemiology and Infection 2010, 25(4):3-4.
11. Gessener B.D., Duclos P., DeRoeck D., Anthony E., Nelson S. Informing decision makers: experience and process of 15 National Immunisation Technical Advisory Groups. Vaccine 2010, 28S:A1-A5.
12. Madhi S. Introduction of the pneumococcal conjugate vaccine into the South African public immunisation programme: a dawn of a new era?. South African Journal of Epidemiology and Infection 2008, 23(4):5-9.
13. National Department of Health South Africa, Expanded Programme on Immunisation. District Health Information System (DHIS). Unpublished. Immunisation Coverage figures available on request.
14. The BIOVAC Institute. (accessed 30 May 2011). http://www.biovac.co.za/company-overview.html.
15. Duclos P., Okwo-Bele J.M., Gacic-Dobo M., Cherian T. Global Immunisation: status, progress, challenges and future. BioMed Central 2009, 14(October (9), Suppl. 1 (S2)).